India Oncogene Inhibitors Market (2025-2031) | Outlook, Industry, Share, Companies, Trends, Size & Revenue, Competitive Landscape, Value, Growth, Forecast, Segmentation, Analysis

Market Forecast By Genes (EGFR, HER, BRCA, Others), By Indication (Breast Cancer, Ovarian Cancer, Lung Cancer, Pancreas Cancer, Others), By Treatment (Platinum-Based Chemotherapy, PARP Inhibitors, Anti-HER Antibodies, EFGR Inhibitors, Others), By Route of Administration (Oral, Parenteral), By End-Users (Hospitals, Specialty Clinics, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) And Competitive Landscape
Product Code: ETC7549464 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Dhaval Chaurasia No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • India Oncogene Inhibitors Market Outlook
  • Market Size of India Oncogene Inhibitors Market, 2024
  • Forecast of India Oncogene Inhibitors Market, 2031
  • Historical Data and Forecast of India Oncogene Inhibitors Revenues & Volume for the Period 2021- 2031
  • India Oncogene Inhibitors Market Trend Evolution
  • India Oncogene Inhibitors Market Drivers and Challenges
  • India Oncogene Inhibitors Price Trends
  • India Oncogene Inhibitors Porter's Five Forces
  • India Oncogene Inhibitors Industry Life Cycle
  • Historical Data and Forecast of India Oncogene Inhibitors Market Revenues & Volume By Genes for the Period 2021- 2031
  • Historical Data and Forecast of India Oncogene Inhibitors Market Revenues & Volume By EGFR for the Period 2021- 2031
  • Historical Data and Forecast of India Oncogene Inhibitors Market Revenues & Volume By HER for the Period 2021- 2031
  • Historical Data and Forecast of India Oncogene Inhibitors Market Revenues & Volume By BRCA for the Period 2021- 2031
  • Historical Data and Forecast of India Oncogene Inhibitors Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of India Oncogene Inhibitors Market Revenues & Volume By Indication for the Period 2021- 2031
  • Historical Data and Forecast of India Oncogene Inhibitors Market Revenues & Volume By Breast Cancer for the Period 2021- 2031
  • Historical Data and Forecast of India Oncogene Inhibitors Market Revenues & Volume By Ovarian Cancer for the Period 2021- 2031
  • Historical Data and Forecast of India Oncogene Inhibitors Market Revenues & Volume By Lung Cancer for the Period 2021- 2031
  • Historical Data and Forecast of India Oncogene Inhibitors Market Revenues & Volume By Pancreas Cancer for the Period 2021- 2031
  • Historical Data and Forecast of India Oncogene Inhibitors Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of India Oncogene Inhibitors Market Revenues & Volume By Treatment for the Period 2021- 2031
  • Historical Data and Forecast of India Oncogene Inhibitors Market Revenues & Volume By Platinum-Based Chemotherapy for the Period 2021- 2031
  • Historical Data and Forecast of India Oncogene Inhibitors Market Revenues & Volume By PARP Inhibitors for the Period 2021- 2031
  • Historical Data and Forecast of India Oncogene Inhibitors Market Revenues & Volume By Anti-HER Antibodies for the Period 2021- 2031
  • Historical Data and Forecast of India Oncogene Inhibitors Market Revenues & Volume By EFGR Inhibitors for the Period 2021- 2031
  • Historical Data and Forecast of India Oncogene Inhibitors Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of India Oncogene Inhibitors Market Revenues & Volume By Route of Administration for the Period 2021- 2031
  • Historical Data and Forecast of India Oncogene Inhibitors Market Revenues & Volume By Oral for the Period 2021- 2031
  • Historical Data and Forecast of India Oncogene Inhibitors Market Revenues & Volume By Parenteral for the Period 2021- 2031
  • Historical Data and Forecast of India Oncogene Inhibitors Market Revenues & Volume By End-Users for the Period 2021- 2031
  • Historical Data and Forecast of India Oncogene Inhibitors Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of India Oncogene Inhibitors Market Revenues & Volume By Specialty Clinics for the Period 2021- 2031
  • Historical Data and Forecast of India Oncogene Inhibitors Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of India Oncogene Inhibitors Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
  • Historical Data and Forecast of India Oncogene Inhibitors Market Revenues & Volume By Hospital Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of India Oncogene Inhibitors Market Revenues & Volume By Retail Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of India Oncogene Inhibitors Market Revenues & Volume By Others for the Period 2021- 2031
  • India Oncogene Inhibitors Import Export Trade Statistics
  • Market Opportunity Assessment By Genes
  • Market Opportunity Assessment By Indication
  • Market Opportunity Assessment By Treatment
  • Market Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By End-Users
  • Market Opportunity Assessment By Distribution Channel
  • India Oncogene Inhibitors Top Companies Market Share
  • India Oncogene Inhibitors Competitive Benchmarking By Technical and Operational Parameters
  • India Oncogene Inhibitors Company Profiles
  • India Oncogene Inhibitors Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the India Oncogene Inhibitors Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the India Oncogene Inhibitors Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 India Oncogene Inhibitors Market Overview

3.1 India Country Macro Economic Indicators

3.2 India Oncogene Inhibitors Market Revenues & Volume, 2021 & 2031F

3.3 India Oncogene Inhibitors Market - Industry Life Cycle

3.4 India Oncogene Inhibitors Market - Porter's Five Forces

3.5 India Oncogene Inhibitors Market Revenues & Volume Share, By Genes, 2021 & 2031F

3.6 India Oncogene Inhibitors Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.7 India Oncogene Inhibitors Market Revenues & Volume Share, By Treatment, 2021 & 2031F

3.8 India Oncogene Inhibitors Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.9 India Oncogene Inhibitors Market Revenues & Volume Share, By End-Users, 2021 & 2031F

3.10 India Oncogene Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 India Oncogene Inhibitors Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in India

4.2.2 Growing adoption of targeted therapies for cancer treatment

4.2.3 Rise in research and development activities in oncology sector

4.3 Market Restraints

4.3.1 High cost of oncogene inhibitors

4.3.2 Stringent regulatory requirements for drug approval

4.3.3 Limited access to advanced cancer treatments in certain regions of India

5 India Oncogene Inhibitors Market Trends

6 India Oncogene Inhibitors Market, By Types

6.1 India Oncogene Inhibitors Market, By Genes

6.1.1 Overview and Analysis

6.1.2 India Oncogene Inhibitors Market Revenues & Volume, By Genes, 2021- 2031F

6.1.3 India Oncogene Inhibitors Market Revenues & Volume, By EGFR, 2021- 2031F

6.1.4 India Oncogene Inhibitors Market Revenues & Volume, By HER, 2021- 2031F

6.1.5 India Oncogene Inhibitors Market Revenues & Volume, By BRCA, 2021- 2031F

6.1.6 India Oncogene Inhibitors Market Revenues & Volume, By Others, 2021- 2031F

6.2 India Oncogene Inhibitors Market, By Indication

6.2.1 Overview and Analysis

6.2.2 India Oncogene Inhibitors Market Revenues & Volume, By Breast Cancer, 2021- 2031F

6.2.3 India Oncogene Inhibitors Market Revenues & Volume, By Ovarian Cancer, 2021- 2031F

6.2.4 India Oncogene Inhibitors Market Revenues & Volume, By Lung Cancer, 2021- 2031F

6.2.5 India Oncogene Inhibitors Market Revenues & Volume, By Pancreas Cancer, 2021- 2031F

6.2.6 India Oncogene Inhibitors Market Revenues & Volume, By Others, 2021- 2031F

6.3 India Oncogene Inhibitors Market, By Treatment

6.3.1 Overview and Analysis

6.3.2 India Oncogene Inhibitors Market Revenues & Volume, By Platinum-Based Chemotherapy, 2021- 2031F

6.3.3 India Oncogene Inhibitors Market Revenues & Volume, By PARP Inhibitors, 2021- 2031F

6.3.4 India Oncogene Inhibitors Market Revenues & Volume, By Anti-HER Antibodies, 2021- 2031F

6.3.5 India Oncogene Inhibitors Market Revenues & Volume, By EFGR Inhibitors, 2021- 2031F

6.3.6 India Oncogene Inhibitors Market Revenues & Volume, By Others, 2021- 2031F

6.4 India Oncogene Inhibitors Market, By Route of Administration

6.4.1 Overview and Analysis

6.4.2 India Oncogene Inhibitors Market Revenues & Volume, By Oral, 2021- 2031F

6.4.3 India Oncogene Inhibitors Market Revenues & Volume, By Parenteral, 2021- 2031F

6.5 India Oncogene Inhibitors Market, By End-Users

6.5.1 Overview and Analysis

6.5.2 India Oncogene Inhibitors Market Revenues & Volume, By Hospitals, 2021- 2031F

6.5.3 India Oncogene Inhibitors Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.5.4 India Oncogene Inhibitors Market Revenues & Volume, By Others, 2021- 2031F

6.6 India Oncogene Inhibitors Market, By Distribution Channel

6.6.1 Overview and Analysis

6.6.2 India Oncogene Inhibitors Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.6.3 India Oncogene Inhibitors Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.6.4 India Oncogene Inhibitors Market Revenues & Volume, By Others, 2021- 2031F

7 India Oncogene Inhibitors Market Import-Export Trade Statistics

7.1 India Oncogene Inhibitors Market Export to Major Countries

7.2 India Oncogene Inhibitors Market Imports from Major Countries

8 India Oncogene Inhibitors Market Key Performance Indicators

8.1 Number of clinical trials using oncogene inhibitors in India

8.2 Adoption rate of personalized medicine in cancer treatment

8.3 Investment in oncology research and development in India

9 India Oncogene Inhibitors Market - Opportunity Assessment

9.1 India Oncogene Inhibitors Market Opportunity Assessment, By Genes, 2021 & 2031F

9.2 India Oncogene Inhibitors Market Opportunity Assessment, By Indication, 2021 & 2031F

9.3 India Oncogene Inhibitors Market Opportunity Assessment, By Treatment, 2021 & 2031F

9.4 India Oncogene Inhibitors Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.5 India Oncogene Inhibitors Market Opportunity Assessment, By End-Users, 2021 & 2031F

9.6 India Oncogene Inhibitors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 India Oncogene Inhibitors Market - Competitive Landscape

10.1 India Oncogene Inhibitors Market Revenue Share, By Companies, 2024

10.2 India Oncogene Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here
Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Related Reports

Industry Events and Analyst Meet

Whitepaper

Read All
Chat With 6W AI Intelligence